{"data":[{"accessionNo":"0001422849-26-000061","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001178670","issuerName":"Alnylam Pharmaceuticals, Inc.","ticker":"ALNY","cusip":"02043Q107","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Capital World Investors","reportingCik":null,"personType":"IA","sharesOwned":10916799,"percentOfClass":8.2,"filedAt":"2026-05-14","canonicalUrl":"https://xoomar.com/markets/stocks/alny"},{"accessionNo":"0001422848-26-000050","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001178670","issuerName":"Alnylam Pharmaceuticals, Inc.","ticker":"ALNY","cusip":"02043Q107","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Capital Research Global Investors","reportingCik":null,"personType":"IA","sharesOwned":9471181,"percentOfClass":7.1,"filedAt":"2026-05-14","canonicalUrl":"https://xoomar.com/markets/stocks/alny"},{"accessionNo":"0000315066-26-001107","formType":"SCHEDULE 13G/A","amendmentNo":23,"issuerCik":"0001178670","issuerName":"ALNYLAM PHARMACEUTICALS INC","ticker":"ALNY","cusip":"02043Q107","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":14640524.87,"percentOfClass":11,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/alny"},{"accessionNo":"0000315066-26-001107","formType":"SCHEDULE 13G/A","amendmentNo":23,"issuerCik":"0001178670","issuerName":"ALNYLAM PHARMACEUTICALS INC","ticker":"ALNY","cusip":"02043Q107","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":14640524.87,"percentOfClass":11,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/alny"},{"accessionNo":"0002100119-26-000160","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001178670","issuerName":"Alnylam Pharmaceuticals Inc","ticker":"ALNY","cusip":"02043Q107","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":7104536,"percentOfClass":5.35,"filedAt":"2026-04-29","canonicalUrl":"https://xoomar.com/markets/stocks/alny"},{"accessionNo":"0000102909-26-000562","formType":"SCHEDULE 13G/A","amendmentNo":10,"issuerCik":"0001178670","issuerName":"Alnylam Pharmaceuticals Inc","ticker":"ALNY","cusip":"02043Q107","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-26","canonicalUrl":"https://xoomar.com/markets/stocks/alny"},{"accessionNo":"0000315066-25-002664","formType":"SCHEDULE 13G/A","amendmentNo":22,"issuerCik":"0001178670","issuerName":"ALNYLAM PHARMACEUTICALS INC","ticker":"ALNY","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":16834094.74,"percentOfClass":12.8,"filedAt":"2025-11-05","canonicalUrl":"https://xoomar.com/markets/stocks/alny"},{"accessionNo":"0000315066-25-002664","formType":"SCHEDULE 13G/A","amendmentNo":22,"issuerCik":"0001178670","issuerName":"ALNYLAM PHARMACEUTICALS INC","ticker":"ALNY","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":16834094.74,"percentOfClass":12.8,"filedAt":"2025-11-05","canonicalUrl":"https://xoomar.com/markets/stocks/alny"}],"updatedAt":"2026-10-29T04:45:25.776Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/alny","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}